Monday, August 31, 2026

Palladium Futures Rises By 3% In The Last 5 Sessions

Palladium Futures Rises By 3% In The Last 5 Sessions

(VIANEWS) - Palladium (PA) has been up by 3.27% for the last 5 sessions. At 22:50 EST on Sunday, 3 March, Palladium (PA) is $963.00.

Volume

Today's last reported volume for Palladium is 127, 99.99% below its average volume of 3706611662.13.

Volatility

Palladium's last week, last month's, and last quarter's current intraday variation average was 0.87%, 0.39%, and 1.89%, respectively.

Palladium's highest amplitude of average volatility was 2.22% (last week), 1.50% (last month), and 1.89% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palladium's commodity is considered to be oversold (<=20).

News about

  • WTI crude oil weekly forecast: intriguing bullish signals and highs attained - 03 March 2024. According to DailyForex on Sunday, 3 March, "Suddenly WTI Crude Oil was touching the 79.500 ratio and the commodity's volatility was not done yet. ", "In the middle of December WTI Crude Oil was trading near the 68.000 ratio briefly. "

More news about Palladium (PA).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com